Effect of phencyclidines on hippocampal pyramidal cells

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Phencyclidine (PCP) is a dissociative anesthetic with complex neurochemical effects.
• Understanding PCP's precise mechanisms of action on hippocampal circuitry is crucial for its clinical and research applications.

Purpose of the Study:

• To investigate the effects of phencyclidine (PCP) and its analogs on CA1 pyramidal cell activity in rats.
• To elucidate the specific neural pathways and mechanisms underlying PCP's actions on hippocampal synaptic transmission.

Main Methods:

• Intravenous administration of PCP and structural analogs to urethane-anesthetized rats.
• Electrophysiological recordings of CA1 pyramidal cell discharges evoked by CA3 stimulation.
• Utilized midcollicular transections and 6-hydroxydopamine lesions to investigate the role of brainstem afferents and noradrenergic innervation.

Main Results:

• Behaviorally active PCP and m-amino PCP dose-dependently reduced the population spike amplitude in CA1, with ED50 values of 0.9 and 0.5 mg/kg, respectively.
• Behaviorally inactive analogs (m-nitro PCP, PCP methyliodide) were ineffective at doses up to 10 mg/kg.
• PCP reduced the duration of inhibition in a paired-stimulus paradigm, an effect dependent on brainstem afferents but independent of hippocampal noradrenergic innervation.

Conclusions:

• PCP exerts at least two distinct central effects on CA1 pyramidal cells.
• PCP-induced decrease in monosynaptic excitation of CA1 cells requires intact brainstem afferents.
• PCP may reduce recurrent inhibition or afterhyperpolarization via a direct hippocampal mechanism, independent of brainstem connections.